Antibody Titration in Hemolytic Disease of the Fetus and Newborn - State of the Art

被引：0
|
作者：
Flommersfeld, Sabine [1 ]
Ertl, Birgit [1 ]
机构：
[1] Univ Klinikum Giessen & Marburg, Zentrum Transfus Med & Hamotherapie, Baldingerstr, D-35043 Marburg, Germany
来源：
TRANSFUSIONSMEDIZIN | 2018年 / 8卷 / 02期
关键词：
alloimmunization; antibody titration; hemolytic disease of the newborn;
D O I：
10.1055/s-0043-121113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Immunohematological results may not correlate with the clinical outcome of patients. Especially in fetomaternal incompatibility it would be desirable to have a validated method for prediction of the clinical relevance of an antibody. Antibody titration is widely used. Quality controls are not standardized and methods and interpretation of results differ. A reliable method for antibody titration is described and its pro's and con's will be discussed.
引用
收藏
页码：90 / 94
页数：5
相关论文
共 50 条
  • [41] SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN DUE TO ANTI-G
    Sareneva, I
    Haimila, K.
    Korhonen, A. E.
    Stefanovic, V
    Kuosmanen, M.
    Sainio, S.
    VOX SANGUINIS, 2012, 103 : 231 - 231
  • [42] Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn
    Moise, K. J., Jr.
    Ling, L. E.
    Oepkes, D.
    Tiblad, E.
    Verweij, E. J. T. J.
    Lopriore, E.
    Smoleniec, J.
    Sachs, U. J.
    Bein, G.
    Kilby, M. D.
    Miller, R. S.
    Devlieger, R.
    Audibert, F.
    Emery, S. P.
    Markham, K.
    Norton, M. E.
    Ocon-Hernandez, O.
    Pandya, P.
    Pereira, L.
    Silver, R. M.
    Windrim, R.
    Streisand, J. B.
    Leu, J. H.
    Mirza, A.
    Smith, V.
    Schwartz, L. B.
    Tjoa, M. L.
    Saeed-Khawaja, S.
    Komatsu, Y.
    Bussel, J. B.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2025, 80 (02) : 77 - 79
  • [43] Fatal hemolytic disease of the fetus and newborn associated with anti-Jra
    Peyrard, Thierry
    Pham, Bach-Nga
    Arnaud, Lionel
    Fleutiaux, Sophie
    Brossard, Yves
    Guerin, Benedicte
    Desmoulins, Isabelle
    Rouger, Philippe
    Le Pennec, Pierre-Yves
    TRANSFUSION, 2008, 48 (09) : 1906 - 1911
  • [44] Maternal IgG in hemolytic disease of the fetus and newborn-ABO incompatibility
    Wibowo, Heri
    Nurrahmah, Sheila
    Gantini, Ria Syafitri Evi
    MEDICAL JOURNAL OF INDONESIA, 2024, 33 (02) : 70 - 74
  • [45] A comparison of techniques for antibody titers in screening for hemolytic disease of the fetus
    Dysart, Suzanne
    Forde, Braxton
    Markham, Kara
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 230 (01) : S97 - S98
  • [46] Schizophrenia: A long-term consequence of hemolytic disease of the fetus and newborn?
    Hollister, JM
    Kohler, C
    INTERNATIONAL JOURNAL OF MENTAL HEALTH, 2000, 29 (04) : 38 - 61
  • [47] Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape
    de Winter, Derek P.
    Kaminski, Allysen
    Tjoa, May Lee
    Oepkes, Dick
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [48] A Case of Hemolytic Disease of the Newborn due to Di(a) Antibody
    Jethava, Ashif
    Olivares, Esperanza
    Shariatmadar, Sherry
    CASE REPORTS IN PEDIATRICS, 2015, 2015
  • [49] Anti-K18 Causing Hemolytic Disease of the Fetus and Newborn
    O'Leary, M. F.
    Larimore, K. S.
    Hue-Roye, K.
    Pirman, M.
    Hancock, H.
    Sausais, L.
    Lomas-Francis, C.
    TRANSFUSION, 2011, 51 : 156A - 156A
  • [50] History and current standard of postnatal management in hemolytic disease of the fetus and newborn
    De Winter, Derek P.
    Hulzebos, Christian
    Van 't Oever, Renske M.
    De Haas, Masja
    Verweij, E. J. T.
    Lopriore, Enrico
    EUROPEAN JOURNAL OF PEDIATRICS, 2023, 182 (02) : 489 - 500
12345